1-1 of 1
Keywords: proteasome inhibitors
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Clin Sci (Lond) (2019) 133 (16): 1827–1844.
Published: 27 August 2019
... risk of cardiotoxicity and HF in young adult animal cardiomyocytes and hearts. anthracyclines bortezomib carfilzomib cardiotoxicity proteasome inhibitors Anthracyclines (ANTs, e.g., doxorubicin or daunorubicin (DAU)) remain among the most widely prescribed anticancer agents, but their...
Includes: Supplementary data